Onco-Innovations Limited (CVE:ONCO) | WebDisclosure

Basculer en Français

10681	Companies
228020	Keywords
156520	Articles
120880	Press releases

Headlines Articles Press releases Onco-Innovations Limited

Home
Companies
Onco-Innovations Limited

BRIEF

published on 04/25/2025 at 00:05, 1 year 2 months ago

Onco-Innovations' Inka Health Partners with AstraZeneca Canada

Real-world Evidence Onco-Innovations Inka Health AstraZeneca Canada Drug Submission
BRIEF

published on 04/25/2025 at 00:05, 1 year 2 months ago

Inka Health d'Onco-Innovations s'associe à AstraZeneca Canada

Preuves Du Monde Réel Onco-Innovations AstraZeneca Canada Inka Santé Soumission De Médicament
PRESS RELEASE

published on 04/25/2025 at 00:00, 1 year 2 months ago

Onco-Innovations' Inka Health Signs New Analytical Work with AstraZeneca Canada to Advance Real-World Evidence in Regulatory Science
Onco-Innovations Limited's subsidiary, Inka Health Corp., partners with AstraZeneca Canada for real-world evidence research in oncology. The new engagement showcases Inka Health's expertise in evidence translation and market access

Oncology Onco-Innovations Limited Inka Health Corp. AstraZeneca Canada Real-world Evidence Research
BRIEF

published on 04/18/2025 at 00:05, 1 year 2 months ago

Onco-Innovations Partners with Dalton Pharma for PNKP Isotope Synthesis

Cancer Research Onco-Innovations PNKP Technology Dalton Pharma Services ADME Studies
BRIEF

published on 04/18/2025 at 00:05, 1 year 2 months ago

Onco-Innovations s'associe à Dalton Pharma pour la synthèse de l'isotope PNKP

Recherche Sur Le Cancer Onco-Innovations Technologie PNKP Services Pharmaceutiques Dalton Études ADME
PRESS RELEASE

published on 04/18/2025 at 00:00, 1 year 2 months ago

Onco-Innovations Announces Partnership with Dalton Pharma for Isotope Synthesis of Patented PNKP Technology
Onco-Innovations partners with Dalton Pharma Services to synthesize heavy labelled PNKP inhibitor for increasing survival rate in colorectal cancer mice. Study showcases promising therapeutic potential

Colorectal Cancer Survival Rate Onco-Innovations Dalton Pharma Services PNKP Inhibitor
BRIEF

published on 04/17/2025 at 01:35, 1 year 2 months ago

Onco-Innovations Plans $600,000 Private Placement

Private Placement Warrants Regulatory Approval Securities Offering Corporate Funding
BRIEF

published on 04/17/2025 at 01:35, 1 year 2 months ago

Onco-Innovations prévoit un placement privé de 600 000 $

Placement Privé Offre De Titres Mandats Financement Des Entreprises Approbation Réglementaire
PRESS RELEASE

published on 04/17/2025 at 01:30, 1 year 2 months ago

Onco-Innovations Announces Private Placement
Onco-Innovations Limited announces a non-brokered private placement of up to 400,000 units at $1.50 per unit, for gross proceeds of up to $600,000, with plans for cancer research and treatment advancements

Private Placement Securities Oncology Cancer Research Onco-Innovations Limited
BRIEF

published on 04/11/2025 at 00:05, 1 year 2 months ago

Onco-Innovations' Inka Health Advances Real-World Oncology Research

Clinical Trials Oncology Research Real-world Data Quantitative Bias Analysis Regulatory Assessments

Accesswire

Published on 07/03/2026 at 23:00, 1 day 23 hours ago

Eagle Plains Partner Refined Energy Announces Final Results for Winter 2026 Drill Program at Dufferin West
Published on 07/03/2026 at 23:00, 1 day 23 hours ago

Medicure Announces CFO Change
Published on 07/03/2026 at 21:28, 2 days ago

Trifecta Gold Announces Closing of $1.66 Million Private Placement
Published on 07/03/2026 at 19:30, 2 days 2 hours ago

Polaris Renewable Energy Announces Q2 2026 Investor Call Details
Published on 07/03/2026 at 13:30, 2 days 8 hours ago

Nextech3D.ai Unveils Strategic AI Growth Roadmap Focused on Workforce Intelligence and Event Technology Innovation

View all ACCESSWIRE

EQS Group

Published on 07/05/2026 at 13:45, 8 hours 34 minutes ago

XPPen renforce son engagement en faveur de l’animation grâce à son partenariat avec la Résidence du Festival d’Annecy 2026 et sa présence au MIFA
Published on 07/05/2026 at 13:45, 8 hours 34 minutes ago

XPPen Strengthens Its Commitment to Animation with 2026 Annecy Festival Residency Partnership and MIFA Showcase
Published on 07/04/2026 at 17:35, 1 day 4 hours ago

Vantage Introduces 24/7 Gold CFD Trading with XAUUSD247
Published on 07/04/2026 at 11:01, 1 day 11 hours ago

EQS-Adhoc: Continental AG: Continental AG Sells ContiTech Group Sector
Published on 07/04/2026 at 09:05, 1 day 13 hours ago

Velo x McLaren Mastercard Formula 1® Team Relaunches Live Your Fandom to Bring Fans Closer to the Sport They Love

Les Echos

Published on 07/03/2026 at 21:49, 2 days ago

Safran annonce la fin des négociations concernant le projet d'acquisition d’Exail Technologies.
Published on 07/03/2026 at 21:49, 2 days ago

Safran announces the end of negotiations regarding the contemplated acquisition of Exail Technologies.
Published on 07/03/2026 at 18:42, 2 days 3 hours ago

Total number of voting rights and shares making up the share capital at June 30, 2026
Published on 07/03/2026 at 18:42, 2 days 3 hours ago

Capital et droits de vote au 30 juin 2026
Published on 07/03/2026 at 18:36, 2 days 3 hours ago

Disclosure of transactions in own shares from July 1 to July 3, 2026

View all LES ECHOS COMFI WIRE